Self-Inactivating Lentiviral Vectors with U3 and U5 Modifications
- 1 August 1999
- Vol. 261 (1), 120-132
- https://doi.org/10.1006/viro.1999.9850
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector systemGene Therapy, 1999
- Regulated Lentiviral Packaging Cell Line Devoid of Most Viralcis-Acting SequencesVirology, 1998
- Sustained expression of genes delivered directly into liver and muscle by lentiviral vectorsNature Genetics, 1997
- Infection and Replication of Tat Human Immunodeficiency Viruses: Genetic Analyses of LTR and tat Mutations in Primary and Long-Term Human Lymphoid CellsVirology, 1995
- CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition.Genes & Development, 1995
- Gene therapy using retroviral vectorsCurrent Opinion in Biotechnology, 1994
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993
- Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR.The EMBO Journal, 1992
- High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and Cellular Biology, 1987
- CELLULAR ONCOGENES AND RETROVIRUSESAnnual Review of Biochemistry, 1983